Latest Tearlab Corp (TEAR) Headlines 5 Hated Ea
Post# of 36
Posted On: 03/13/2014 2:42:56 PM
Latest Tearlab Corp (TEAR) Headlines
5 Hated Earnings Stocks You Should Love
at The Street - Tue Mar 11, 11:27AM CDT
These heavily shorted stocks could get squeezed much higher if they report positive earnings this week.
TearLab to Participate in March Investor Conferences
GlobeNewswire - Tue Mar 04, 8:00AM CST
TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) ("TearLab" or the "Company") announced today that the Company will participate in three investor conferences in March.
TearLab Corporation to Release Q4 and Full Year 2013 Financial Results on March 13, 2014
GlobeNewswire - Mon Mar 03, 3:30PM CST
TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) expects to announce its Q4 2013 and full year 2013 financial results after market closes on Thursday, March 13, 2014. TearLab is pleased to invite all willing participants in a conference call during which time financial results will be discussed. This call will be held at 4:30pm Eastern at 877-303-1593.
3 Stocks Under $10 Moving Higher
at The Street - Fri Feb 28, 5:00AM CST
When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.
TearLab to Acquire AOA's OcuHub Technology Platform
GlobeNewswire - Tue Feb 18, 7:02AM CST
TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) ("TearLab" or the "Company") today announced it has signed a non-binding term sheet to purchase the assets of the OcuHub business unit from AOAExcel, Inc., the for-profit subsidiary of the American Optometric Association ("AOA").
5 Stocks Ready to Explode Higher
at The Street - Wed Feb 12, 1:13PM CST
These stocks could be sett9ing up for explosive moves higher soon.
TearLab Announces Preliminary Fourth Quarter 2013 Revenue and Issues 2014 Revenue Guidance
GlobeNewswire - Mon Feb 03, 7:00AM CST
TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) ("TearLab" or the "Company") today announced total revenue for the fourth quarter of 2013 is expected to be approximately $4.5 million, bringing expected full year 2013 revenues to approximately $14.7 million. These figures are preliminary and unaudited and final revenues may differ. The Company currently expects to report final 2013 financial results on March 13, 2014.
TearLab (TEAR) in Focus: Stock Tumbles 7% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Jan 29, 7:39AM CST
TearLab ompany’s shares fell by over 7% yesterday. This recent price action is discouraging, so make sure to keep a close watch on this firm in the near future, and especially on earnings estimates following the recent slump.
TearLab Reports on Launch of a New 1,000 Patient Multi-Center DED Prevalence Study in the UK
GlobeNewswire - Tue Dec 17, 7:00AM CST
In collaboration with the United Kingdom's National Health Service (NHS), four ophthalmologists are beginning a large 1,000 patient multi-center study to assess the overall prevalence of Dry Eye Disease ("DED").
Changes in Senior Management, Exchange Transaction, Financial Results, and Public Offering of Shares - Research Report on Bristol-Myers Squibb, HealthSouth, TearLab, Synta, and Ophthotech
PR Newswire - Mon Nov 18, 7:00AM CST
Today, Analysts' Corner announced new research reports highlighting Bristol-Myers Squibb Company (NYSE: BMY), HealthSouth Corp. (NYSE: HLS), TearLab Corporation (NASDAQ: TEAR), Synta Pharmaceuticals Corp. (NASDAQ: SNTA), and Ophthotech Corporation (NASDAQ: OPHT). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.
Why TearLab Corp. Shares Dipped
Sean Williams, The Motley Fool - Motley Fool - Wed Nov 13, 12:09PM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of TearLab , an ophthalmic (i.e.,...
TearLab Corporation Reports Q3-13 Financial Results
GlobeNewswire - Tue Nov 12, 3:03PM CST
TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) ("TearLab" or the "Company") today reported its consolidated financial results for the third quarter ended September 30, 2013. All dollar amounts are expressed in U.S. currency and results are reported in accordance with United States generally accepted accounting principles.
4 Stocks Triggering Breakouts on Big Volume
at The Street - Mon Nov 11, 7:18AM CST
These stocks trading on unusual volume are within range of triggering major breakout trades.
TearLab to Participate in the 2013 Stephens Fall Investment Conference
GlobeNewswire - Wed Nov 06, 3:45PM CST
TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) ("TearLab" or the "Company") announced today that its Chief Executive Officer, Elias Vamvakas, will present an update on the Company's business at the Stephens Fall Investment Conference on Wednesday, November 13 at 11:00 a.m. Eastern Time. The conference will take place at the New York Palace Hotel in New York City.
6 Strong Small Cap Stocks For A Growing Economy
at The Street - Mon Oct 28, 4:01PM CDT
TearLab Corporation to Release Q3 2013 Financial Results on November 12, 2013
GlobeNewswire - Mon Oct 21, 4:30PM CDT
TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) expects to announce its Q3 2013 financial results after market closes on Tuesday November 12, 2013. TearLab is pleased to invite all willing participants in a conference call during which time financial results will be discussed. This call will be held at 4:30pm Eastern at 877-303-1593.
TearLab Corporation Announces Inducement Grant Under NASDAQ Rule 5635(c)(4)
GlobeNewswire - Mon Oct 21, 3:45PM CDT
TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) ("TearLab" or the "Company") today announced that on October 21, 2013, a majority of the independent members of the Company's Board of Directors approved the grant of an option to purchase 300,000 shares of the Company's common stock to Joseph Jensen, the Company's President and Chief Operating Officer. The stock option has a ten-year term and a per share exercise price equal to the higher of (i) the closing price per share of the Company's common stock as quoted on the Nasdaq Capital Market on October 21, 2013 or (ii) the prior five-day volume weighted average price of the Company's common stock as quoted on the Nasdaq Capital Market at the close of business on October 21, 2013. The stock option has a vesting commencement date of October 21, 2013, Mr. Jensen's start date with the Company, and will vest in equal annual increments over a three year period, subject to Mr. Jensen's continued service with the Company through each applicable vesting date. In addition, the stock option will fully accelerate as to vesting in the event of a change of control prior to Mr. Jensen's termination of service. The stock option grant was made as an inducement that was material to Mr. Jensen's acceptance of employment with the Company and was granted as an employment inducement award pursuant to NASDAQ Listing Rule 5635(c)(4).
Empire Asset Management Company (CRD 143007) initiates coverage on TearLab (NASDAQ:TEAR) with a Sell rating
PR Newswire - Tue Oct 08, 8:25AM CDT
Today Empire Asset Management Company a FINRA member (143007), initiated coverage of TearLab (NASDAQ:TEAR) with a Sell rating and 12 month price target of $4.00.
TearLab to Participate in Craig-Hallum's 4th Annual Alpha Select Conference
GlobeNewswire - Thu Sep 19, 8:20AM CDT
TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) ("TearLab" or the "Company") announced today that its Chief Executive Officer, Elias Vamvakas, will present an update on the Company's business at the 4th Annual Craig-Hallum Alpha Select Conference on Thursday, September 26, 2013 at 8:35 a.m. Eastern Time in New York City.
5 Hated Earnings Stocks You Should Love
at The Street - Tue Mar 11, 11:27AM CDT
These heavily shorted stocks could get squeezed much higher if they report positive earnings this week.
TearLab to Participate in March Investor Conferences
GlobeNewswire - Tue Mar 04, 8:00AM CST
TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) ("TearLab" or the "Company") announced today that the Company will participate in three investor conferences in March.
TearLab Corporation to Release Q4 and Full Year 2013 Financial Results on March 13, 2014
GlobeNewswire - Mon Mar 03, 3:30PM CST
TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) expects to announce its Q4 2013 and full year 2013 financial results after market closes on Thursday, March 13, 2014. TearLab is pleased to invite all willing participants in a conference call during which time financial results will be discussed. This call will be held at 4:30pm Eastern at 877-303-1593.
3 Stocks Under $10 Moving Higher
at The Street - Fri Feb 28, 5:00AM CST
When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.
TearLab to Acquire AOA's OcuHub Technology Platform
GlobeNewswire - Tue Feb 18, 7:02AM CST
TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) ("TearLab" or the "Company") today announced it has signed a non-binding term sheet to purchase the assets of the OcuHub business unit from AOAExcel, Inc., the for-profit subsidiary of the American Optometric Association ("AOA").
5 Stocks Ready to Explode Higher
at The Street - Wed Feb 12, 1:13PM CST
These stocks could be sett9ing up for explosive moves higher soon.
TearLab Announces Preliminary Fourth Quarter 2013 Revenue and Issues 2014 Revenue Guidance
GlobeNewswire - Mon Feb 03, 7:00AM CST
TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) ("TearLab" or the "Company") today announced total revenue for the fourth quarter of 2013 is expected to be approximately $4.5 million, bringing expected full year 2013 revenues to approximately $14.7 million. These figures are preliminary and unaudited and final revenues may differ. The Company currently expects to report final 2013 financial results on March 13, 2014.
TearLab (TEAR) in Focus: Stock Tumbles 7% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Jan 29, 7:39AM CST
TearLab ompany’s shares fell by over 7% yesterday. This recent price action is discouraging, so make sure to keep a close watch on this firm in the near future, and especially on earnings estimates following the recent slump.
TearLab Reports on Launch of a New 1,000 Patient Multi-Center DED Prevalence Study in the UK
GlobeNewswire - Tue Dec 17, 7:00AM CST
In collaboration with the United Kingdom's National Health Service (NHS), four ophthalmologists are beginning a large 1,000 patient multi-center study to assess the overall prevalence of Dry Eye Disease ("DED").
Changes in Senior Management, Exchange Transaction, Financial Results, and Public Offering of Shares - Research Report on Bristol-Myers Squibb, HealthSouth, TearLab, Synta, and Ophthotech
PR Newswire - Mon Nov 18, 7:00AM CST
Today, Analysts' Corner announced new research reports highlighting Bristol-Myers Squibb Company (NYSE: BMY), HealthSouth Corp. (NYSE: HLS), TearLab Corporation (NASDAQ: TEAR), Synta Pharmaceuticals Corp. (NASDAQ: SNTA), and Ophthotech Corporation (NASDAQ: OPHT). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.
Why TearLab Corp. Shares Dipped
Sean Williams, The Motley Fool - Motley Fool - Wed Nov 13, 12:09PM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of TearLab , an ophthalmic (i.e.,...
TearLab Corporation Reports Q3-13 Financial Results
GlobeNewswire - Tue Nov 12, 3:03PM CST
TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) ("TearLab" or the "Company") today reported its consolidated financial results for the third quarter ended September 30, 2013. All dollar amounts are expressed in U.S. currency and results are reported in accordance with United States generally accepted accounting principles.
4 Stocks Triggering Breakouts on Big Volume
at The Street - Mon Nov 11, 7:18AM CST
These stocks trading on unusual volume are within range of triggering major breakout trades.
TearLab to Participate in the 2013 Stephens Fall Investment Conference
GlobeNewswire - Wed Nov 06, 3:45PM CST
TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) ("TearLab" or the "Company") announced today that its Chief Executive Officer, Elias Vamvakas, will present an update on the Company's business at the Stephens Fall Investment Conference on Wednesday, November 13 at 11:00 a.m. Eastern Time. The conference will take place at the New York Palace Hotel in New York City.
6 Strong Small Cap Stocks For A Growing Economy
at The Street - Mon Oct 28, 4:01PM CDT
TearLab Corporation to Release Q3 2013 Financial Results on November 12, 2013
GlobeNewswire - Mon Oct 21, 4:30PM CDT
TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) expects to announce its Q3 2013 financial results after market closes on Tuesday November 12, 2013. TearLab is pleased to invite all willing participants in a conference call during which time financial results will be discussed. This call will be held at 4:30pm Eastern at 877-303-1593.
TearLab Corporation Announces Inducement Grant Under NASDAQ Rule 5635(c)(4)
GlobeNewswire - Mon Oct 21, 3:45PM CDT
TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) ("TearLab" or the "Company") today announced that on October 21, 2013, a majority of the independent members of the Company's Board of Directors approved the grant of an option to purchase 300,000 shares of the Company's common stock to Joseph Jensen, the Company's President and Chief Operating Officer. The stock option has a ten-year term and a per share exercise price equal to the higher of (i) the closing price per share of the Company's common stock as quoted on the Nasdaq Capital Market on October 21, 2013 or (ii) the prior five-day volume weighted average price of the Company's common stock as quoted on the Nasdaq Capital Market at the close of business on October 21, 2013. The stock option has a vesting commencement date of October 21, 2013, Mr. Jensen's start date with the Company, and will vest in equal annual increments over a three year period, subject to Mr. Jensen's continued service with the Company through each applicable vesting date. In addition, the stock option will fully accelerate as to vesting in the event of a change of control prior to Mr. Jensen's termination of service. The stock option grant was made as an inducement that was material to Mr. Jensen's acceptance of employment with the Company and was granted as an employment inducement award pursuant to NASDAQ Listing Rule 5635(c)(4).
Empire Asset Management Company (CRD 143007) initiates coverage on TearLab (NASDAQ:TEAR) with a Sell rating
PR Newswire - Tue Oct 08, 8:25AM CDT
Today Empire Asset Management Company a FINRA member (143007), initiated coverage of TearLab (NASDAQ:TEAR) with a Sell rating and 12 month price target of $4.00.
TearLab to Participate in Craig-Hallum's 4th Annual Alpha Select Conference
GlobeNewswire - Thu Sep 19, 8:20AM CDT
TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) ("TearLab" or the "Company") announced today that its Chief Executive Officer, Elias Vamvakas, will present an update on the Company's business at the 4th Annual Craig-Hallum Alpha Select Conference on Thursday, September 26, 2013 at 8:35 a.m. Eastern Time in New York City.
(0)
(0)TearLab Corp. (TEAR) Stock Research Links
Scroll down for more posts ▼